Clinical Trials Directory

Trials / Unknown

UnknownNCT04488731

The Effect of Coffee Consumption on the Serum Levels of Leptin, Folic Acid, and Vitamin B12

The Effect of Coffee Consumption and Body Weight on the Serum Levels of Leptin, Folic Acid, and Vitamin B12 in Young Males: A Cross-Sectional Study

Status
Unknown
Phase
Study type
Observational
Enrollment
120 (estimated)
Sponsor
Applied Science Private University · Academic / Other
Sex
Male
Age
18 Years – 26 Years
Healthy volunteers
Accepted

Summary

The effect of coffee and body weight during the last 3 months on the level of leptin, folic acid, and vitamin B12

Detailed description

Coffee consumption has been associated with several risk factors leading to cardiovascular diseases (CVDs), including hyperhomocysteinemia and hyperlipidemia. Frequent coffee consumption has beneficial effects in reducing the risk of diabetes mellitus (DM) type 2, obesity, liver disease, CVDs, some types of cancer, Parkinson's disease, and Alzheimer's disease. Controversies concerning coffee consumption benefits and risks in regards for CVDs were mentioned in many studies. Folic acid and vitamin B12 are necessary vitamins in homocysteine metabolism which is a risk factor for atherosclerosis. Leptin, is a hormone linked to obesity and it could be related to atherosclerosis. The combined effect of coffee consumption and body weight on the levels of leptin, folic aid, and vitamin B12 is not well studied. In our study, we will study the effect of coffee consumption in males with different body mass indices to see the effect of several important parameters such as leptin, Folic acid, and vitamin B12.

Conditions

Interventions

TypeNameDescription
BEHAVIORALNormal BMI and moderate coffee consumptionNormal BMI and moderate coffee consumption
BEHAVIORALNormal BMI and heavy coffee consumptionNormal BMI and heavy coffee consumption
BEHAVIORALoverweight and moderate coffee consumptionoverweight and moderate coffee consumption
BEHAVIORALoverweight and heavy coffee consumptionoverweight and heavy coffee consumption

Timeline

Start date
2020-07-26
Primary completion
2020-09-26
Completion
2020-10-26
First posted
2020-07-28
Last updated
2020-08-14

Locations

1 site across 1 country: Jordan

Source: ClinicalTrials.gov record NCT04488731. Inclusion in this directory is not an endorsement.